Gliomas are the most common and malignant intracranial tumours in adults. Recent studies have 2 shown that functional genomics greatly aids in the understanding of the pathophysiology and 3 therapy of glioma. However, comprehensive genomic data and analysis platforms are relatively 4 limited. In this study, we developed the Chinese Glioma Genome Atlas (CGGA, 5 http://www.cgga.org.cn), a user-friendly data portal for storage and interactive exploration of multi-6 dimensional functional genomic data that includes nearly 2,000 primary and recurrent glioma 7 samples from Chinese cohorts. CGGA currently provides access to whole-exome sequencing (286 8 samples), messenger RNA sequencing (1,018 samples) and microarray (301 samples), DNA 9 methylation microarray (159 samples), and microRNA microarray (198 samples) data, as well as 10 detailed clinical data (e.g., WHO grade, histological type, critical molecular genetic information, 11 age, sex, chemoradiotherapy status and survival data). In addition, we developed an analysis tool to 12 allow users to browse mutational, mRNA/microRNA expression, and DNA methylation profiles and 13 perform survival and correlation analyses of specific glioma subtypes. CGGA greatly reduces the 14 barriers between complex functional genomic data and glioma researchers who seek rapid, intuitive, 15 and high-quality access to data resources and enables researchers to use these immeasurable data 16 sources for biological research and clinical application. Importantly, the free provision of data will 17 allow researchers to quickly generate and provide data to the research community. 18 19
We also developed an analysis module to allow users to browse the mutational landscape profile, 12 mRNA/microRNA expression profile and DNA methylation profile as well as to perform survival 13 and correlation analyses for specific glioma subtypes. We believe that this website will greatly 14 reduce the barriers between complex functional genomic data and glioma researchers who seek 15 rapid, intuitive, and high-quality access to data resources.
16

Results
17
Database content and usage 18 The CGGA database was designed to store functional genomic data and to allow interactive 19 exploration of multi-dimensional datasets from primary and recurrent gliomas in Chinese cohorts; 20 it is available at http://www.cgga.org.cn/. Currently, CGGA contains whole-exome sequencing data 21 (286 samples), messenger RNA sequencing data (total: 1,018 samples, batch 1 with 693 samples 22 and batch 2 with 325 samples), microarray data (301 samples), DNA methylation microarray data 23 (159 samples), and microRNA microarray data (198 samples) for glioma. The database also contains 24 detailed clinical data (including WHO grade and histological type, critical molecular genetic 25 information, age, sex, chemoradiotherapy status and survival data). Detailed statistical information 26 for each dataset is provided in Table 1 . We organized the web interface of CGGA according to the 27 three main functional features: (i) Home, (ii) Analyse, and (iii) Download. In the following context, 28 we provide an example for using CGGA. The home page 1 On the 'Home' page, CGGA provides a statistical table for a glioma dataset, including the dataset 2 name, data type, number of samples in each subgroup, clinical data and analysis purposes. For 3 instance, we performed messenger RNA sequencing on 1,018 glioma samples included in two 4 datasets (693 samples in batch 1 and 325 samples for batch 2, including 282 primary LGGs, 161 5 recurrent LGGs, 140 primary GBMs and 109 recurrent GBMs in batch 1 and 144 primary LGGs, 6 38 recurrent LGGs, 85 primary GBMs, 24 recurrent GBMs and 30 secondary GBMs in batch 2). To 7 the best of our knowledge, CGGA is the first database to store the functional genomic data for both 8 LGG and GBM recurrent gliomas. In addition, users can obtain a visualized result for the analysis 9 of each dataset for a specific glioma subtype by clicking on a hyperlink on the 'Home' page. The 10 'Download' and 'Help' pages can also be accessed directly from the 'Home' page.
11
Overall analyses and results
12
To facilitate analysis of the CGGA data by researchers, we developed four online modules in the 13 'Analyse' tab, including 'WEseq data', 'mRNA data', 'methylation data', and 'microRNA data', to 14 analyse whole-exome, mRNA expression, DNA methylation and microRNA expression data, 15 respectively ( Figure 1A) . A key feature of CGGA is that it is easy to use. In the context below, we 16 demonstrate the use of the 'Analyse' tab in CGGA.
17
On the 'WEseq data' page, users are allowed to visualize the mutational profile of a gene set 18 of interest and survival analysis of a specific gene of interest in a specific glioma subtype. In the 19 'Oncoprint' section, users are guided to a) input a gene set of interest ('IDH1 TP53 ATRX' for 20 example), and b) select a dataset of interest ('All' for example). Based on user input, this tool 21 automatically generates visualized results. In this result, each case or patient is represented as 22 columns, each gene is displayed as rows, and a colour map on the bottom is used to depict specific 23 clinical information (Figure 1B) . This 'Oncoprint' can be very useful for visualizing the mutational 24 profile for a gene set of interest in a specific glioma subtype and for intuitively validating trends 25 such as mutational frequency and mutual exclusivity or co-occurrence for a gene pair. In the above 26 example, mutations in the IDH1 (47%), TP53 (46%) and ATRX (30%) genes were the most common 27 mutations in all gliomas. In the 'Survival' section, users are allowed to a) input a specific gene of 28 interest ('IDH1' for example), and b) select a dataset of interest ('Primary LGG' for example) to 29 investigate the association of the mutation with severe functional consequences. Consistent with 30 7 previous studies [24] , primary LGG cases with IDH1 mutations have a better overall survival than 1 do cases with IDH1 wild-type tumours (p < 0.0001, Figure 1C , left). These analysis results from 2 the 'WEseq data' section can be exported as a PDF file. For the sake of reproducibility, we provide 3 the analysis data (Figure 1C , middle) and R code (Figure 1C, right) , which allow users to reproduce 4 the figure to be able to modify or adapt each figure according to each researcher's demands.
5
On the 'mRNA data' page, users are allowed to perform gene expression distribution, 6 correlation and survival analyses for a specific gene of interest in a specific glioma subtype. Three 7 mRNA datasets are available for users, including two batch RNA-seq datasets (batch 1: 693 samples; 8 batch 2: 325 samples) and one microarray dataset (301 samples). In the 'Distribution' section, users 9 can display one gene distribution pattern for each glioma subtype by selecting a dataset 10 ('mRNAseq_325' for example) and inputting a gene name of interest ('ADAMTSL4' for example).
11
The results show the gene expression pattern in each glioma subtype classified by clinical 12 information. Similar to our previous studies [25], the ADAMTSL4 gene was shown to be 13 differentially expressed according to the WHO 2016 classification based on the IDH mutation 14 and/or 1p/19q co-deletion status (Figure 1D, left) . Moreover, a critical feature of the CGGA dataset 15 is the inclusion of recurrent gliomas. This module allows users to infer whether a gene may be a 16 candidate factor that drives malignant progression if it is differentially expressed in primary and 17 recurrent gliomas. In the 'Correlation' section, the user is allowed to validate the co-expression 18 pattern by selecting a dataset ('mRNAseq_325' for example) and inputting a gene pair 19 ('ADAMTSL4' and 'CD274' for example). As a result, the co-expression patterns in each glioma 20 subtype will be displayed with the results of Pearson's test and the p value (Figure 1D , middle). In 21 the 'Survival' section, users can perform survival analysis based on gene expression by selecting a 22 dataset ('mRNAseq_325' for example) and inputting a gene of interest ('ADAMTSL4' for example).
23
All primary glioma patients with low ADAMTSL4 expression showed better overall survival than 24 did those with high ADAMTSL4 expression (p < 0.0001, Figure 1D , right). The above results from 25 the 'mRNA data' section are consistent with our previous study [25] . Similar to the 'mRNA data' 26 page, users can also display the methylation/microRNA distribution and perform correlation and 27 survival analyses on the 'methylation data' page and the 'microRNA data' page, respectively. All the data sets in CGGA can be downloaded on the 'Download' page by both the community and 1 researchers. Each data type is saved at the gene and/or probe level and is then combined with the 2 available clinical data, including basic clinical information, survival and therapy information. The current version of the CGGA is the first release of our database, and it incorporates multi-5 dimensional functional genomic glioma data, including whole-exome sequencing, mRNA and 6 microRNA expression, and DNA methylation data for nearly 2,000 samples from Chinese cohorts.
7
Considering the importance of these data for glioma research, CGGA is publicly available. To the 8 best of our knowledge, CGGA is the first database to store the functional genomic data for both 9 recurrent LGGs and GBMs. In addition, CGGA provides several tools that allow users to analyse 10 these datasets, including mutational profile, distribution pattern, correlation and survival analysis 11 tools. These tools will be useful for users to generate or validate findings of novel biological 12 significance. 13 We anticipate several future directions for our CGGA database. First, through the Beijing 14 Neurosurgical Institute, Beijing Tiantan Hospital and Chinese Glioma Cooperative Group (CGCG) 15 Research Network, we will continue to collect glioma samples and perform multiple 'Omics' 16 sequencing/microarray analyses, and we will continue to update this database regularly in the future.
17
Second, we also plan to add image-genomic data that match the 'Omics' data in CGGA. Third, we 18 will develop more advanced features, including data for other 'Omics' analyses, search functions 19 for clinical information on a patient of interest, and further extensions for the data analysis tools. In 20 summary, CGGA facilitates access to functional genomic data for Chinese cohorts for the entire 21 glioma community. It provides an easy-to-use, user-friendly interface for obtaining integrated data 22 sets, performing intuitive visualized analysis, and downloading these datasets. CGGA greatly 23 reduces the barriers between complex functional genomic data and glioma researchers, which 24 empowers researchers to use functional genomic data into important biological insights and 25 potential clinical applications. method. In particular, mutations with a significantly higher mutation allele frequency in tumours 27 than in normal controls were selected.
28
Data processing for mRNA sequencing data 29 Prior to library preparation, total RNA was isolated using RNeasy Mini Kit (Qiagen) according to 1 the manufacturer's instructions. A pestle and QIAshredder (Qiagen) were used to disrupt and 2 homogenize frozen tissue. The RNA intensity was checked using a 2,100 Bioanalyzer (Agilent 3 Technologies), and only high-quality samples with an RNA integrity number (RIN) value greater 4 than or equal to 6.8 were used to construct the sequencing library. Typically, 1 μg of total RNA was 5 used with the TruSeq RNA library preparation kit (Illumina) in accordance with the low-throughput 6 protocol, except that SuperScript III reverse transcriptase (Invitrogen) was used to synthesize first- Extraction Software (Version 9.1). GeneSpring GX11.0 was applied to calculate the probe intensity.
3 Data processing for methylation microarray data 4 A haematoxylin and eosin-stained frozen section was prepared for assessment of the percentage of 5 tumour cells before RNA extraction. Only samples with greater than 80% tumour cells were selected.
6
Genomic DNA was isolated from frozen tumour tissues using the QIAamp DNA Mini Kit (Qiagen) 7 according to the manufacturer's protocol. The DNA concentration and quality were assessed using 8 a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Houston, TX). The microarray 9 analysis was performed using Illumina Infinium HumanMethylation27 Bead-Chips (Illumina Inc.), 10 which contains 27,578 highly informative CpG sites covering more than 14,000 human RefSeq 11 genes. This allows researchers to investigate all sites per sample at a single-nucleotide resolution.
12
Bisulfite modification of DNA, chip processing and data analysis were performed following the 13 manufacturer's manual at Wellcome Trust Centre for Human Genetics Genomics Lab, Oxford, UK. In CGGA, all data are organized with MySQL 14.14 based on relational schema, which will be 24 supported by future CGGA updates. The website code was written based on Java Server Pages using 25 the Java Servlet framework. The website is deployed on the Tomcat 6.0.44 web server and runs on 26 a CentOS 5.5 Linux system. JQuery was used to generate, render and manipulate data visualization.
27
The 'Analyse' module was realized with Perl and R scripts. The CGGA website has been fully tested 28 in Google Chrome and Safari browsers. Figure 1 . An overview of the CGGA database.
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A. The CGGA contains whole-exome sequencing, mRNA and microRNA expression, and DNA 3 methylation data, clinical data, and several analysis modules; B. The mutation profile in all gliomas 4 (in the 'WSseq_286' dataset); C. left: the overall survival of glioma patients with IDH1 mutation 5 and the wild-type gene from primary LGGs (in the 'WSseq_286' dataset); middle: the data was used 6 to generate the plot; right: the R code was used to generate the plot; D. left: the ADAMTSL4 gene 7 expression distribution in primary gliomas based on 2016 WHO grading system (in the 8 'mRNAseq_325' dataset); middle: the gene expression correlation between ADAMTSL4 and 9 CD274 genes (using 'mRNAseq_325' dataset); right: the overall survival of glioma patients with 10 low and high ADAMTSL4 gene expression (in the 'mRNAseq_325' dataset). 
